|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
Tuesday
Betaseron: Bayer Extends Schering Offer to Win More Investors
"Chief Executive Officer Werner Wenning wants to buy Schering to help rebuild the company's drug division and gain products such as the Betaseron multiple sclerosis medicine....Bayer held 18.49 percent of Schering yesterday.....that still leaves it short of the 75 percent it set as a threshold...." |